Oscar Health, Inc. (NYSE:OSCR) Earnings Report Analysis

Core Insights - Oscar Health reported an EPS of -$1.24, missing the consensus estimate of -$0.84, and revenue of $2.81 billion, below the Zacks Consensus Estimate of $3.21 billion [1][2] - The company's EPS of -$1.24 represents a decline from the previous year's -$0.62, resulting in an EPS surprise of -47.62% [2] - Despite exceeding consensus EPS estimates three times in the past four quarters, the current results highlight ongoing challenges faced by the company [2] Financial Metrics - Oscar Health has a debt-to-equity ratio of 0.72, indicating moderate leverage [1][3] - The current ratio stands at 0.95, suggesting potential liquidity issues [1][3] - The price-to-sales ratio is 0.26 and the enterprise value to sales ratio is 0.19, indicating a relatively low valuation compared to its sales [3] - The negative P/E ratio of -14.22 and earnings yield of -7.03% reflect ongoing losses [3] Market Position and Challenges - Oscar Health leverages technology to simplify healthcare but faces significant competition within the insurance industry [2] - High utilization of medical services by plan enrollees is impacting the company's financial performance [2] - Despite current challenges, Oscar Health remains optimistic about achieving profitability within the year [2]